The p53 tumor suppressor gene belongs to a multigene family that includes two paralogues, p63 and p73. p73a has common activities with p53, such as DNA binding and transactivation, and can thus activate the transcription of p53-responsive genes. Using the adenoviral system, we report that an overexpression of either wt-p73a or one of the two transcriptional inactive mutants, DNp73a or p73aR292H, induces an accumulation of the endogenous wt-p53 expressed in the three transformed cell lines, SK-N-SH, MCF-7 and U-2OS, without stimulating the p53 gene transcription. p73-mediated accumulation of p53 protein coincides with an increase of p53-target gene expression in cells expressing either wt-p73a or the transcriptional inactive mutant p73aR292H, but not DNp73a that encodes a dominant-negative mutant of both p73 and p53. The fact that an ectopic expression of p73aR292H leads to both accumulation of p53 and stimulation of p53 target gene expression strongly suggests that p73a is able to induce activation of p53. This was confirmed by showing that p73aR292H no longer stimulated Waf1/p21 expression in MCF7/R-A1 cells that expressed a transcriptional inactive mutant of p53. We thus conclude that p73a protein was able to both stabilize and activate wt-p53 protein, independent of the p73a transcriptional activity. Oncogene (2003 Oncogene ( ) 22, 5451-5456. doi:10.1038 Keywords: p53; p73a; p73aR292H; recombinant adenovirus; protein stability; transcriptional activity
The tumor suppressor gene p53 plays a central role in preserving genomic integrity by arresting cell cycle progression or activating apoptosis after various stresses (DNA damage, heat shock, hypoxia, osmotic shock). In response to a cellular stress, the p53 protein is stabilized and activated by post-translational modifications such as phosphorylation, acetylation and sumoylation, as well as by protein interaction with cofactors. Once activated, p53 binds to specific DNA sequences, leading to an upregulation of its target genes, notably responsible for cell cycle arrest like p21/waf1, promotion of apoptosis, for example, Bax and fas or its own inactivation like MDM2 that encodes a ubiquitin ligase (May and May, 1999) . In normal cells MDM2 targets p53 for ubiquitin-mediated proteolysis, establishing an autoregulatory feedback loop. Interference with p53/ MDM2 interaction leads to p53 protein accumulation and subsequent p53-dependent cellular responses.
Although p53 was long considered to be unique, recently two p53-related genes, p73 and p63, were discovered (Kaghad et al., 1997; Yang et al., 1998 Yang et al., , 2002 . Searches in the recently published human genome sequences did not reveal any other putative p53 family members (Irwin and Kaelin, 2001 ). p73 and p63 encode proteins with high sequence homology to p53. In particular, the amino-acid residues implicated in direct sequence-specific DNA binding are conserved, suggesting that p73 and p63 could perform certain 'p53-like activities'. Indeed, similar to p53, both p63 and p73 can form homo-oligomers, bind DNA, activate transcription of p53-responsive genes and induce apoptosis (Levrero et al., 2000) . However, p63 and p73 were described as more involved in embryonic development than in tumor suppression (Mills et al., 1999; Yang et al., 2000) .
In contrast to p53, p63 and p73 give rise to multiple functionally distinct protein isoforms, some of which differ at their carboxyl-terminal ends as a result of differential splicing, while others lack the aminoterminal transactivation domain (DN isoforms). DNp73 can function as a 'dominant-negative' mutant not only on full-length p73 (TAp73) but also on p53, by direct competition for DNA binding to p53-responsive elements (Grob et al., 2001; Stiewe et al., 2002a) . As a consequence, DNp73 antagonizes the transcriptional activity of p53 and prevents p53-induced cell death (Fillippovich et al., 2001; Kartasheva et al., 2002) .
Transcription of the two sets of DN and TA isoforms is regulated independently, although transcribed from the same gene. DNp73 isoforms are expressed from a second internal promoter within intron 3. The internal promoter is upregulated by direct binding of either TA isoforms or p53 (Grob et al., 2001; Kartasheva et al., 2002; Nakagawa et al., 2002; Vossio et al., 2002) . Thus, the positive transcriptional regulation of DNp73 by TAp73 and p53, taken together with the negative effect of DNp73 on p53 and TAp73 transcriptional activity, creates a negative feedback loop that could regulate both TAp73 and p53 functions (Grob et al., 2001; Kartasheva et al., 2002; Vossio et al., 2002) .
The present study provides evidence of an additional level of complexity in the crosstalk between the p53-family members. We showed that p73a protein could stabilize and activate wt-p53 protein and that this effect is independent of the p73a transcriptional activity. This was performed by introducing expression of transcriptional inactive mutants of p73a within human transformed cells expressing wt-p53. The three cell lines analysed were SK-N-SH, MCF-7 and U-2OS, derived from a neuroblastoma, a breast carcinoma and an osteosarcoma, respectively. These cells were infected with recombinant adenovirus expressing either wt-p73a (Ad-p73a) or one of the two transcriptional-deficient mutants, DNp73a (Ad-DNp73a) or p73aR292H (Adp73aR292H). As already mentioned, DNp73a protein could act as a transrepressor mutant of p53 by competing for binding to p53-responsive elements (RE). Conversely, the mutant p73aR292H, which is both defective for DNA binding to p53RE (Jost et al., 1997) and unable to form hetero-oligomers with p53, could not inactivate the transcriptional activity of p53 (Stiewe et al., 2002a) .
We first controlled the efficiency of adenoviral infection by infecting cells with a recombinant adenovirus expressing the green fluorescent protein (GFP), at a multiplicity of infection (moi) of 5 and 30 infectious particles per cell (PFU). The results obtained with U-2OS cells are presented in Figure 1 . Nearly 100% of the cells were already infected at an moi as low as 5 PFU. Increasing the moi leads to a higher intracellular level of GFP as judged by the fluorescence intensity. Similar results were obtained with MCF-7 and SK-N-SH (data not shown).
The three cell lines were then infected with the p73-expressing recombinant adenovirus, Ad-DNp73a and Ad-p73aR292H. In parallel, the cells were either mock infected (NI) or infected with an empty recombinant adenovirus (Ad-C). Expression of p73 was detected by Western blots, 30 h after infection. Using up to 35 mg total protein extract, no endogenous p73 was detected in any of the three cell lines, either mock infected ( Figure 2 , lane 1) or infected with the control recombinant adenovirus (Figure 2 , lane 6). In contrast, an ectopic expression of DNp73a and p73aR292H is already detectable at the lower moi of 5 PFU ( Figure 2 , lanes 2 and 7, respectively). Moreover, levels of these two proteins increase with the moi in the interval of 5-60 PFU (Figure 2 , lanes 2-5 and lanes 7-10, respectively). Probing the same blot with a monoclonal antibody directed against human p53 revealed that the expression of the two transcriptional-deficient mutants provokes a dose-dependent elevation of p53 protein level as compared to either mock-or control adenovirusinfected cells (Figure 2 ). The same results were obtained by infecting the cells with the recombinant adenovirus Ad-TAp73a that codes, for the transcription active TAp73a protein (Figure 3, panel a) .
Most of the time, accumulation of p53 protein results from post-translational modifications that lead to p53 protein stabilization (May and May, 1999) . However, there are a few examples showing that regulation of p53 expression can occur at the transcriptional level (Draneé t al., 2002) . To discriminate between these two alternatives, endogenous p53 mRNA was quantified from cells infected at an moi of 30 PFU, by real-time detection of PCR products. The results, presented in Table 1 , show no significant increase in p53 mRNA levels, irrespective of the cell line analysed and the recombinant adenovirus used for infection, strongly suggesting that the increase of p53 protein accumulation brought on by an ectopic expression of either p73a, DNp73a or p73aR292H does not result from an upregulation of p53 gene transcription.
In several cases, it has been reported that p53 accumulation is dissociated from its activation as a transcriptional factor (Drane´et al., 2002) . We thus examined if the p73-mediated accumulation of p53 protein coincided with an increase of p53-target gene expression. With this aim we first looked for an effect of p73 expression on Waf1/p21 at the protein level. Western blot results are presented in Figure 2 . As expected, expression of Waf1/p21 protein was not 5) or Ad-p73aR292H (lanes 7-10) at an moi of 5 (lanes 2 and 7), 10 (lanes 3 and 8), 30 (lanes 4 and 9) and 60 (lanes 5, 6 and 10). At 30 h after infection, the cells were lysed with the following buffer: 62.5 mm Tris/ HCl pH 6.9, 2 mm EDTA, 10% glycerol, 2% SDS. A quantity of 35 mg of total protein extracts was loaded on a 12% SDS-polyacrylamide gel. After electrophoresis, the proteins were transferred to a nitrocellulose membrane BA-S 83 (Optitran, Schleicher & Schuell) and stained with Ponceau-S to ensure even loading of protein samples. Membrane was then blocked in 5% nonfat milk-0.2% Tween in TBS (10 mm Tris/HCl pH 8, 150 mm NaCl) and probed successively with the following primary antibodies: anti-p53 (DO-7 supernatant; 1 : 5000 dilution), anti-p21 (Pharmingen, cat. no. 556430; 1 : 500 dilution), antip73 (Oncogene cat. no. OP108L; 1 : 5000 dilution) and anti-hMDM2 (4B11 supernatant, Chen et al., 1993; 1 : 10 dilution) . After incubation with the secondary antibody conjugated with horseradish peroxidase (Santa Cruz; 1 : 10 000 dilution), detection was performed with Chemiluminescence Reagent Plus (NEN). The asterisks indicate a nonspecific protein revealed with 4B11 Figure 3 The mutant p73aR292H stabilizes p53 to the same extent as TAp73a (a), but is unable to activate the transcription from a p53RE (b). (a) Western blot analysis of p73 and p53 protein in cells mock infected (lane 1), infected with either Ad-C (lane 2) or recombinant adenovirus expressing either DNp73a (lane 3), p73aR292H (lane 4) or TAp73a (lane 5). MCF-7 cells were seeded at 2 Â 10 6 cells in 100 mm diameter Petri dish. After 24 h, the cells were infected at an moi of 60 PFU and lysed 30 h after infection with 200 ml of 50 mm HEPES pH 7, 250 mm NaCl, 0.1% NP-40, 1 mm DTT, 2 mm EDTA and 4 mm Pefabloc (Roche). A quantity of 35 mg of total protein was loaded on a 12% SDS-polyacrylamide gel. Western blot was probed successively with the monoclonal antibody 4B11 to reveal p73a and DO-7 to reveal p53 as decribed in the legend of Figure 2 . Even loading of protein samples was ensured by probing the membranes with an antibody against ERK1/2 (NEB cat. no. 9102; 1 : 1000 dilution). (b) H1299 cells were seeded at 2 Â 10 5 cells in six-well plates and transfected with 0.5 mg of the pE1B-hWAF1 firefly luciferase reporter using the calcium phosphate method as previously described (Drane´et al., 2001) . At 24 h after transfection, cells were infected with 30 PFU of Ad-C (lane 6), Ad-p73a (lane 7) or Ad-p73aR292H (lane 8). After 24 h, cells were lysed with 200 ml/well of passive lysis buffer provided with the 'luciferase assay kit' (Promega). The luciferase activity was measured according to the manufacturer's protocol, as previously described (Drane´et al., 2001) . Results are expressed relative to Ad-C infected cells. Error bars represent standard deviation calculated from three independent experiments p53 activation by a DNA-binding negative mutant of p37a F Miro-Mur et al whose expression was put under the control of the p53RE of Waf1/p21 gene, and then infected with either Ad-p73a or Ad-p73aR292H. Data presented in Figure 3 (panel b) confirmed that p73aR292H is unable to activate the reporter gene expression. Taken altogether, these results show that p73a is able to increase the intracellular level of Waf1/p21 through a mechanism independent of its transcriptional activity. Ectopic expression of p73aR292H also provoked a dosedependent accumulation of hMDM2, which is encoded by another well-characterized p53 target gene (Figure 2 , compare lanes 7-10 with lane 6). However, in contrast to Waf1/p21, an ectopic expression of DNp73a has no effect on the basal level of hMDM2 (compare lanes 2-5 with lane 6).
To determine if an upregulation of Waf1/p21 and hMDM2 gene transcription might account for the accumulation of Waf1/p21 and hMDM2 proteins detected in cells expressing the p73-transcriptional inactive mutant p73aR292H, the corresponding mRNA was quantified by quantitative real-time PCR. As compared to mock-infected cells (NI) or to cells infected with an empty recombinant adenovirus (Ad-C), Waf1/ p21 mRNA level was significantly increased in the three cell lines following infection with Ad-p73aR292H (Figure 4, panel a) , showing that an ectopic expression of the transcriptional inactive p73aR292H mutant leads to an upregulation of Waf1/p21 gene transcription. Similar results were obtained by quantifying mRNA of hMDM2 as well as Bax, another well-characterized p53 target gene (Figure 4 , panels b and c). Except for Waf1/ p21 in MCF-7 cells, mRNA levels of these three genes are comparable in cells expressing either the mutant p73aR292H or the transcriptional active form TAp73a, indicating that p73a stimulates the transcription of p53 The experimental protocol is similar to that described in the legend of Figure 4 . p53 cDNA was amplified with the oligonucleotide pair
Results are normalized relative to GAPDH. NI: mock-infected cells Figure 4 Upregulation of p21/waf1, Bax and hMDM2 gene transcription in response to an ectopic expression of either DNp73a, p73aR292H or TAp73a. SK-N-SH, U-2OS, MCF-7 and MCF-7/R-A1 cells were mock infected (NI) or infected with Ad-C, Adp73aR292H (p73R292H), Ad-DNp73a (DNp73) or Ad-p73a (TAp73) at an moi of 30 PFU. At 30 h after infection, total RNA was extracted using the RNA-plus solution (Bioprobe) as previously described (Drane´et al., 2002) . Reverse transcription was performed on 3 mg of total RNA using oligo dT (Sigma) and AMV reverse transcriptase as described by the manufacturer (Promega (Figure 2 ), indicate that the basal expression of hMDM2 is independent of p53. We then hypothesize that an ectopic expression of p73a leads not only to the stabilization of the endogenous wt-p53 expressed in SKNSH, U-2OS and MCF-7 cells but also to its activation. To further support this hypothesis, Ad-DNp73a and Adp73aR292H were used to infect the MCF-7/R-A1 cells that expressed a transcriptional inactive mutant of p53 (Cai et al., 1997; Drane´et al., 2001) . Results are presented in Figure 4 (panel d). As expected, Waf1/p21 gene expression is not diminished by DNp73a in MCF-7/R-A1 cells and is no longer stimulated by p73aR292H, reinforcing the assumption that the stimulation of p53-target genes identified in response to an ectopic expression of p73aR292H occurs through the endogenous p53-transcriptional activation.
We thus conclude that p73 could stimulate the transcription of p53-target genes not only directly by binding to a p53RE but also indirectly by activating the p53 transcriptional activity. This supposition infers that p73 mutated within its DNA-binding domain could still act as a tumor suppressor through wt-p53 activation. It is tempting to correlate this potential function of p73 with published data showing that, contrary to p53, p73 is rarely mutated in human tumors (Irwin and Kaelin, 2001; Stiewe et al., 2002b) .
Functional cooperation between p53 and p73 and (or) p63 has already been described. Zhu et al. (2001) showed that p73 cooperated with DNA damage to stimulate the Waf1/p21 gene expression in MCF-7 cells. On the other hand, Flores et al. (2002) found that the combined absence of p63 and p73 impaired the induction of p53-dependent apoptosis in response to DNA damage in E1A-expressing MEF cells and in developing mouse central nervous system. According to these authors, p63 and p73 might regulate the ability of p53 to bind at certain selected promoters in response to DNA damage, possibly by cooperating at the promoter level. Our results revealed that p73a could activate p53 independent of the p73a-DNA-binding activity.
In normal cells, p53 stability and activity is regulated through its interaction with MDM2. MDM2 also binds p73 and reduces p73's activity as a transcription factor. However, unlike p53, the steady-state amount of p73a protein is not reduced in the presence of MDM2 (Balint et al., 1999; Zeng et al., 1999) . One potentially important consequence of the interaction between p73a and MDM2 could be the prevention of MDM2-mediated degradation of p53 through MDM2 titration. However, this does not account for the stabilization of p53 identified in cells infected with Ad-DNp73a since the MDM2-binding site of p73a, which was mapped within the N-terminal domain of the protein between the aa 1 and 70 (Zeng et al, 1999) , is missing in DNp73a (Stiewe et al., 2002b) . This, together with the fact that p73aR292H might lead to accumulation of hMDM2, suggests that p73a is able to induce both p53 accumulation and activation independent of its transcriptional activity and its ability to associate with hMDM2.
